Viridian Therapeutics, Inc. (VRDN) Other Long Term Debt Noncurrent — Quarterly & Annual

Screener

Other Long Term Debt Noncurrent at other companies

OrthoPediatricsKIDS

$2.02M+284%

OGS

ONE GASOGS

$2.13B+0.1%

Warner Music GroupWMG

$666M—

Nuvation BioNUVB

$0-100%

Six Flags EntertainmentFUN

$1.44B-0.8%

Viridian Therapeutics, Inc.VRDN

$113.64M—

Other financials

Income statement

Revenue$284.0K+279%

Operating income-$126.3M-18.3%

Net income-$127.1M-26.2%

EPS (diluted)-$1.15-5.5%

Balance sheet

Cash & equivalents$165.0M+40.6%

Total debt$114.4M+395%

Total equity$662.1M+28.5%

Total assets$1.1B+88.4%

Cash flow

Operating cash flow-$105.3M-39.7%

CapEx$1.3M+3,010%

Free cash flow-$106.6M-41.4%

Valuation

Market cap$2.55B+81.7%

Enterprise value$2.5B+90.9%

P/S35.9×-4,565×

Profitability

Gross margin36.3%—

Operating margin-569.7%-284pp

Net margin-544.1%-271pp

FCF margin-471%-235pp

Returns & leverage

Return on equity-65.7%-0.1pp

Debt / equity0.2×+0.1×

Current ratio16.9×+5.9×

Where this comes from

Reported directly by Viridian Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OtherLongTermDebtNoncurrent.

The source filing: Viridian Therapeutics, Inc.’s 10-Q, filed August 6, 2026. Open the filing →

Filed: Aug 6, 2026, 7:31 AM EDT
Fiscal quarter: Q2 FY2026
Calendar quarter: Q2 2026
Accession: 0001590750-26-000018

FAQ

What is Viridian Therapeutics, Inc.'s other long term debt noncurrent?: Viridian Therapeutics, Inc. (VRDN) reported other long term debt noncurrent of $113.64M in Q2 2026.
What does other long term debt noncurrent mean?: Other Long Term Debt Noncurrent as reported by Viridian Therapeutics, Inc. Common Stock.

Ask your AI about Viridian Therapeutics, Inc.'s other long term debt noncurrent.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk